Save Page settings
IBM Watson for Drug Discovery
Barrow Neurological Institute applied cognitive computing with IBM’s Watson for Drug Discovery to identify 5 novel RNA binding proteins altered in ALS.
Request your free trial
Transformational healthcare solutions from Truven Health Analytics®, now offered by IBM Watson Health.
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Resource Type
TEST


Watson is helping Barrow Neurological Institute identify 5 new proteins linked to amyotrophic lateral sclerosis (ALS)


Watch the video
Resource Type
Jonathan Rezek, a long time IBM sales executive along with the University of Toronto used the power of Watson for Drug Discovery to accelerate Drug Repurposing for Parkinson’s Disease.

Watch the video
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
Watch the video
Make scientific breakthroughs and increase your knowledge of disease - faster than ever before.
Watson for Drug Discovery (WDD) helps researchers identify novel drug targets and new indications for existing drugs (drug repurposing). The cloud-based platform can help researchers uncover new connections rapidly, which may lead to new insights and scientific breakthroughs.

Barrow Neurological Institute applied cognitive computing with IBM's Watson for Drug Discovery to identify 5 novel RNA binding proteins altered in ALS.

Preliminary findings:

  • RAPID EXPLORATION: Within weeks, using predictive modeling, rank ordered ~1,500 RNA binding proteins for their association to ALS. Validated through retrospective analysis.
  • VALIDATED PREDICTIONS: Barrow examined Watson's top evidence-based predictions & found 8 of the top 10 ranked proteins were linked to the disease.
  • NEW DISCOVERY: Uncovered 5 never before linked proteins altered in patients with ALS.
Read the research paper
Request your free trial
Using Artificial Intelligence and Advanced Natural Language Processing...
Accelerate your scientific research today and get the answers to your key research questions. Simply fill out the form to request your own personal free trial.
Request your free trial
Drug Repurposing
Vadem te ad mortem tyranno dabis pro amico
Let Watson for Drug Discovery answer your Questions...

CTA Label
Vast data sources
Watson for Drug Discovery brings together a large corpus of knowledge to draw its predicative power. These sources are updated every 3 weeks, so you always have the latest research at your fingertips.
CTA Label
Cognitive
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Visual analytics
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Title
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Title
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Title
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Read the research paper
"Watson now has uncovered five new proteins, RNA binding proteins that are changed in patients with ALS."

Dr. Robert Bowser PhD,
Professor and Chairman of Neuroscience,
Barrow Neurological Institute


Watson for Drug Discovery (WDD) helps researchers identify novel drug targets and new indications for existing drugs (drug repurposing). The cloud-based platform can help researchers uncover new connections rapidly, which may lead to new insights and scientific breakthroughs.

Barrow Neurological Institute applied cognitive computing with IBM's Watson for Drug Discovery to identify 5 novel RNA binding proteins altered in ALS.

Preliminary findings:

  • RAPID EXPLORATION: Within weeks, using predictive modeling, rank ordered ~1,500 RNA binding proteins for their association to ALS. Validated through retrospective analysis.
  • VALIDATED PREDICTIONS: Barrow examined Watson's top evidence-based predictions & found 8 of the top 10 ranked proteins were linked to the disease.
  • NEW DISCOVERY: Uncovered 5 never before linked proteins altered in patients with ALS.
Simply fill out the form to gain access to the full research paper
Event details title
calendar January 1, 2010
time 10:00 AM - 11:00 AM PST
person John Doe
Watson now has uncovered five new proteins, RNA binding proteins that are changed in patients with ALS.
-Dr. Robert Bowser, PhD
Professor and Chairman of Neuroscience, Barrow Neurological Institute
Which compounds are good for which targets?
John Doe,
ille Siculo fecit
Which type of biological pathways should we consider?
John Doe,
ille Siculo fecit
Quote copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
John Doe,
ille Siculo fecit
Quote copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
John Doe,
ille Siculo fecit
Transformational healthcare solutions from Truven Health Analytics®, now offered by IBM Watson Health.
APOLLO NOSCERE NOSMET
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos danda nescio
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
CTA Label
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos danda nescio
CTA Label
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.